国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

INVESTIGATE THE TOXICOLOGICAL EFFECT ON AQUEOUS EXTRACT OF TERMINALIA CATAPPA LINN. IN RAT

Saurabh Arjariya, Nitin Nema, Swati Tiwari

Terminalia catappa (almond) is a combretaceous plant whose leaves are widely used as a folk medicine for treatments of dermatitis, hepatitis, inflammatory disease, diabetes and other disease. This investigation was conceded out to evaluate the safety of aqueous extract of Terminalia catappa Linn. by determining its potential toxicity in rats. Study on acute toxicity of extract found to be safe at the doses 2000mg/kg body weight orally as per OECD guidelines No.423. General behavior, sign of tremors, adverse effects and mortality activity were determined for up to 14 days. In the chronic toxicity study, the aqueous extract of Terminalia Catappa linn. was administered orally at doses of 100, 200 and 400 mg/kg once in a week for 6 weeks to rats. Biochemical and hematological parameters were determined after 6 weeks. In the acute study in rats, there was no toxicity/ death was observed at the dose of 2000mg/kg b.w. The onset of toxicity and signs of toxicity also not there. In the chronic toxicity study, no significant treatment-related changes in the levels of hematological, hepatic and renal parameters such as SGOT, SGPT, cholesterol, creatinine, urea, uric acid, protein and glucose, and serum ALP activities were observed at the termination of the study. It suggests that the aqueous extract of Terminalia catappa linn. does not have significant toxicity. In view of the dose of Terminalia Catappa linn. devoted in traditional medicine, there is a broad margin of safety for the beneficial use of the aqueous extract of Terminalia catappa linn. leaves.